Pediatrix Medical Group, Inc. financial data

Symbol
MD on NYSE
Industry
Services-Hospitals
Location
1301 Concord Terrace, Sunrise, FL
State of incorporation
Florida
Fiscal year end
December 31
Former names
MEDNAX, INC. (to 6/21/2022)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 136 % +13.2%
Debt-to-equity 158 % -0.38%
Return On Equity -29.8 % -361%
Return On Assets -11.6 % -362%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85.9M shares +2.29%
Common Stock, Shares, Outstanding 85.8M shares +2.28%
Entity Public Float 1.18B USD -5.31%
Common Stock, Value, Issued 858K USD +2.39%
Weighted Average Number of Shares Outstanding, Basic 83.3M shares +1.13%
Weighted Average Number of Shares Outstanding, Diluted 83.3M shares +0.81%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 227M USD +0.54%
Operating Income (Loss) -213M USD -232%
Nonoperating Income (Expense) -54.9M USD -54%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -268M USD -312%
Income Tax Expense (Benefit) -16M USD -152%
Net Income (Loss) Attributable to Parent -252M USD -345%
Earnings Per Share, Basic -1.57 USD/shares -228%
Earnings Per Share, Diluted -1.57 USD/shares -228%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.4M USD +232%
Accounts Receivable, after Allowance for Credit Loss, Current 274M USD +1.22%
Other Assets, Current 9.94M USD -1.72%
Assets, Current 429M USD +7.91%
Deferred Income Tax Assets, Net 124M USD +22.2%
Property, Plant and Equipment, Net 47.9M USD -34.7%
Operating Lease, Right-of-Use Asset 61.7M USD +10.6%
Goodwill 1.24B USD -19.1%
Other Assets, Noncurrent 79.5M USD -31.9%
Assets 2B USD -13.5%
Accounts Payable, Current 32M USD +3.25%
Liabilities, Current 310M USD -3.17%
Long-term Debt and Lease Obligation 618M USD -2.21%
Deferred Income Tax Liabilities, Net 30.6M USD -18.9%
Operating Lease, Liability, Noncurrent 49.2M USD +14.2%
Other Liabilities, Noncurrent 31.5M USD -1.27%
Liabilities 1.29B USD -5.45%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.95M USD +44.5%
Retained Earnings (Accumulated Deficit) -298M USD -541%
Stockholders' Equity Attributable to Parent 706M USD -25%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 706M USD -25%
Liabilities and Equity 2B USD -13.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -125M USD -24.1%
Net Cash Provided by (Used in) Financing Activities 76.2M USD -29.8%
Net Cash Provided by (Used in) Investing Activities -16.2M USD -43.1%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 85.8M shares +2.28%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -65.3M USD -1664%
Deferred Tax Assets, Valuation Allowance 436M USD +1.56%
Deferred Tax Assets, Gross 686M USD -1.45%
Operating Lease, Liability 68.3M USD +3.82%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -250M USD -346%
Lessee, Operating Lease, Liability, to be Paid 76.5M USD +8.27%
Property, Plant and Equipment, Gross 218M USD -11.1%
Operating Lease, Liability, Current 18.8M USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17.4M USD -9.46%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.1M USD +0.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +21.7%
Deferred Income Tax Expense (Benefit) 686K USD -65.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.23M USD +68%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.4M USD +2.25%
Deferred Tax Assets, Operating Loss Carryforwards 34.7M USD +20.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 2.45M USD -13.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.91M USD +16.7%
Depreciation, Depletion and Amortization 37.4M USD +3.84%
Deferred Tax Assets, Net of Valuation Allowance 251M USD -6.27%
Share-based Payment Arrangement, Expense 9.3M USD -31.1%
Interest Expense 41.4M USD +0.67%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%